AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

National Cancer Institute at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

National Cancer Institute brings 2 presentations to AMP 2026 in Seattle. Its program covers best practice guidance for artificial intelligence and machine learning in molecular diagnostics, and an award lecture on how lymphoma diagnosis has changed over the decades. The agency funds and conducts cancer research as part of the National Institutes of Health.

OrganizationAMP 2026 Attendance
Gov/NGO
US federal agency funding and conducting cancer research, part of the National Institutes of Health.
Award
Thu, Nov 12
8:45am–10:00am
The Long and Winding Road of Lymphoma Diagnosis
An award lecture on how immunological and molecular tools transformed lymphoma classification over five decades, told through case vignettes.
Talk
Sat, Nov 14
1:15pm–1:45pm
AMP Best Practice Guidance for Artificial Intelligence (AI) and Machine Learning (ML) for Molecular Diagnostics Part 1 Working Group
Best practices for validating and deploying AI models in clinical molecular workflows, and how they differ from older machine learning.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at National Cancer Institute

Tell us what you sell and we’ll find the people at National Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction